Alternatively, plasma VEGF-C may represent a positive prognostic factor in HCC, independent of treatment modality, as has been shown for the absence of cirrhosis in some HCC studies (reviewed in [43]). This evidence concerns the gene VEGFC and hepatocellular carcinoma.